A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AbbVie gains European Commission approval for SKYRIZI® to treat moderate to severe ulcerative colitis in adults; supported by two pivotal Phase 3 trials showing clinical remission
Published: July 26, 2024 by AbbVie Inc.
European Commission approves Pfizer's DURVEQTIX® gene therapy for hemophilia B; reduces bleeds post-treatment with a median annualized bleed rate of zero bleeds after up to four years of follow-up
Published: July 25, 2024 by Pfizer Inc.
GlobalData: FDA approves OTC continuous glucose monitors from Dexcom and Abbott, designed for individuals who don't use insulin; high prediabetes prevalence expected to drive global market of OTC CGMs to reach US$5.1B by 2033
Published: July 23, 2024 by GlobalData Plc
Johnson & Johnson seeks FDA approval for depression nasal spray monotherapy; J&J aims to expand Spravato's indication for treatment-resistant depression in adults
Published: July 22, 2024 by FiercePharma
Roche's Susvimo shows sustained efficacy over two years in Phase III diabetic eye studies; FDA accepts application for diabetic macular edema and retinopathy treatments based on one-year results
Published: July 18, 2024 by F. Hoffmann-La Roche Ltd. (Roche)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count